[Ethiopathogenetic features and course of ischemic stroke associated with COVID-19]

L B Novikova1, R F Latypova1

  • 1Bashkir State Medical University, Ufa, Russia.

Insights

COVID-19 patients experienced more severe ischemic strokes, often with unknown causes and elevated inflammatory markers. Cardiovascular risk factors were less common, suggesting unique disease pathways requiring further investigation.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Cardiology

Context:

  • The association between COVID-19 and ischemic stroke is an emerging area of clinical concern.
  • Understanding the unique characteristics of stroke in COVID-19 patients is crucial for effective management.

Purpose:

  • To investigate the etiopathogenetic factors and clinical course of ischemic stroke in patients with COVID-19.
  • To compare stroke characteristics and risk factors between COVID-19 positive and negative ischemic stroke patients.

Summary:

  • A retrospective study of 173 COVID-19 positive and 86 COVID-19 negative ischemic stroke patients revealed significant differences.
  • COVID-19 patients had less frequent cardiovascular risk factors but experienced more severe strokes, with a higher prevalence of unknown subtypes (TOAST classification).
  • Elevated renal-hepatic markers and C-reactive protein indicated systemic inflammation in the COVID-19 group.

Impact:

  • Findings highlight that COVID-19 influences stroke severity and etiology, independent of traditional cardiovascular risk factors.
  • The increased severity and distinct etiological profile in COVID-19 associated strokes necessitate tailored diagnostic and therapeutic strategies.
  • Further research is warranted to elucidate the negative prognostic impact of cardiovascular disease in COVID-19 patients and optimize treatment.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
33
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
21
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
427
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
24